However, the level of β-catenin was significantly altered with and without ARL4C knockdown, suggesting that ARL4C is a downstream factor in ccRCC that can be affected by altered Wnt/β-catenin signaling (Figures 8(d)–8(f)). Here, ARL4C is linked to nonpapillary renal cell carcinoma.